Walleye Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.4M | Buy |
61,771
+53,575
| +654% | +$28.1M | 0.13% | 64 |
|
|
2025
Q1 | $5.2M | Sell |
8,196
-1,878
| -19% | -$1.19M | 0.02% | 342 |
|
|
2024
Q4 | $7.18M | Buy |
10,074
+2,807
| +39% | +$2M | 0.02% | 342 |
|
|
2024
Q3 | $7.64M | Buy |
7,267
+2,367
| +48% | +$2.49M | 0.02% | 326 |
|
|
2024
Q2 | $5.15M | Buy |
4,900
+425
| +9% | +$447K | 0.01% | 457 |
|
|
2024
Q1 | $4.31M | Buy |
4,475
+2,425
| +118% | +$2.33M | 0.01% | 485 |
|
|
2023
Q4 | $1.8M | Buy |
+2,050
| New | +$1.8M | ﹤0.01% | 677 |
|
|
2023
Q3 | – | Sell |
-21,673
| Closed | -$15.6M | – | 2841 |
|
|
2023
Q2 | $15.6M | Buy |
21,673
+21,473
| +10,737% | +$15.4M | 0.06% | 80 |
|
|
2023
Q1 | $164K | Buy |
+200
| New | +$164K | ﹤0.01% | 1389 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2529 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2665 |
|
|
2021
Q3 | – | Sell |
-3,415
| Closed | -$1.91K | – | 1748 |
|
|
2021
Q2 | $1.91K | Buy |
+3,415
| New | +$1.91K | 0.07% | 246 |
|
|
2020
Q4 | – | Sell |
-589
| Closed | -$330K | – | 1074 |
|
|
2020
Q3 | $330K | Buy |
+589
| New | +$330K | 0.04% | 469 |
|
|
2020
Q2 | – | Sell |
-468
| Closed | -$228K | – | 754 |
|
|
2020
Q1 | $228K | Buy |
468
+78
| +20% | +$38K | 0.05% | 270 |
|
|
2019
Q4 | $146K | Buy |
390
+380
| +3,800% | +$142K | 0.01% | 425 |
|
|
2019
Q3 | $3K | Hold |
10
| – | – | ﹤0.01% | 461 |
|
|
2019
Q2 | $3K | Sell |
10
-443
| -98% | -$133K | ﹤0.01% | 457 |
|
|
2019
Q1 | $186K | Buy |
+453
| New | +$186K | 0.03% | 82 |
|